Encube's Generic Tretinoin Receives Approval in the U.S.
Taro's Generic Tretinoin Receives Approval in the U.S.
Enforcement Report - Week of June 29, 2022
Solaris Pharma's Generic Clindamycin and Tretinoin Receives Approval in the U.S.
Enforcement Report - Week of February 9, 2022
A Phase III clinical trial has found that the combination of all-trans retinoic acid and arsenic trioxide is highly effective in children with standard- and high-risk acute promyelocytic leukaemia (APL).
The FDA on Monday said eight types of sartan medicine to treat high blood pressure have been recalled after being found to contain a potential carcinogen, Taipei Times reported.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that the first patient has been dosed in the dose confirmation study of SY-2101, a novel oral form of arsenic trioxide (ATO). The trial will evaluate the pharmacokinetics (PK), safety, and tolerability of SY-2101 to confirm the optimal dose to advance into a planned Phase 3 clinical trial in newly diagnosed acute promyelocytic leukemia (APL) patients.
Health Canada Issues Recall of New Almanic International`s Splash Corporation Maxi-Peel Exfoliant product recall
The Scottish Medicines Consortium (SMC) has announced its latest round of decisions for NHS Scotland, publishing advice accepting three new medicines.